4 news items
Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO®
EXAS
24 May 24
the importance of tumor biology and support further investigation into the intricate factors contributing to disparities in outcomes to address them
Exact Sciences Announces First-Quarter 2024 Results
EXAS
8 May 24
time and resources; the outcome of any litigation, government investigations, enforcement actions or other legal proceedings; and our ability
Exact Sciences To Present Late-Breaking Data From ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test At AACR Annual Meeting 2024
EXAS
8 Apr 24
demonstrating the compelling performance of its investigational multi-biomarker class, multi-cancer early detection (MCED) blood test. These results
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
EXAS
8 Apr 24
demonstrating the compelling performance of its investigational multi-biomarker class, multi-cancer early detection (MCED) blood test. These results validate
- Prev
- 1
- Next